» Articles » PMID: 36918794

Prevalence and Outcomes of Rapidly Progressive Dementia: a Retrospective Cohort Study in a Neurologic Unit in China

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2023 Mar 15
PMID 36918794
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rapidly progressive dementia (RPD) is a syndrome originating from various diseases. Recent advances have allowed a better understanding of its categories and spectrum; however, it remains challenging to make an accurate differential diagnosis and prognosis prediction.

Methods: This study was a retrospective evaluation of all participants admitted to the neurology department of a single center in China from January 2015 to December 2019. The screened patients met the RPD criteria and their characteristics were collected to explore a diagnostic pattern of RPD. In addition, outcomes of RPD were evaluated with the Glasgow Outcome Scale (GOS), activities of daily living scale (ADL), and simplified Mini-Mental State Examination (MMSE), and different prognostic analysis methods were performed to determine the prognostic factors of RPD.

Results: A total of 149 RPD patients among 15,731 inpatients were identified with an average MMSE value of 13.0 ± 4.6 at baseline. Etiological epidemiology revealed infectious, neurodegenerative and toxic/metabolic diseases as the three largest groups, accounting for 26.2%, 20.8% and 16.8% of all cases, respectively. In particular, prevalence rates of Creutzfeldt-Jakob disease (13.4%), Alzheimer's disease (11.4%), carbon monoxide poisoning (8.1%), neurosyphilis (5.4%) and dementia with Lewy bodies (5.4%) were highest in this series. A recommended diagnostic framework for RPD etiology was thus established. Follow-up evaluations showed a negative correlation between age and GOS scores (r=-0.421, P < 0.001), as well as age and simplified MMSE scores (r =- 0.393, P < 0.001), and a positive correlation between age and ADL scores (r =0.503, P < 0.001), and significantly different GOS, ADL and simplified MMSE scores across various etiologies (P = 0.003; F = 9.463, P < 0.001; F = 6.117, P < 0.001).

Conclusion: Infectious, neurodegenerative and toxic-metabolic entities were the most common RPD categories, and establishing a practical approach to RPD etiology would allow better disease management.

Citing Articles

Etiologies of rapidly progressive dementias: A systematic review and meta-analysis of causes in worldwide and Latin America.

Cubas Guillen J, Cristalli C, Berrios W, Deschle F, Dorman G, Boccazzi J J Alzheimers Dis Rep. 2025; 9:25424823251314505.

PMID: 40034520 PMC: 11864264. DOI: 10.1177/25424823251314505.


Factors influencing physical activity behavior in older adults with subjective cognitive decline: an empirical study using SEM and fsQCA methods.

Li W, Hong S, Chen Y, Zhao Y, Wang L Front Public Health. 2024; 12:1409614.

PMID: 39484360 PMC: 11526387. DOI: 10.3389/fpubh.2024.1409614.


A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region.

Devenney E, Anh N Nguyen Q, Tse N, Kiernan M, Tan R Lancet Reg Health West Pac. 2024; 50:101192.

PMID: 39399870 PMC: 11471059. DOI: 10.1016/j.lanwpc.2024.101192.


Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.

Gonzalez-Ortiz F, Karikari T, Bentivenga G, Baiardi S, Mammana A, Turton M Alzheimers Dement. 2023; 20(1):745-751.

PMID: 37858957 PMC: 10841678. DOI: 10.1002/alz.13516.


Improving Early Recognition of Treatment-Responsive Causes of Rapidly Progressive Dementia: The STAM P Score.

Satyadev N, Tipton P, Martens Y, Dunham S, Geschwind M, Morris J Ann Neurol. 2023; 95(2):237-248.

PMID: 37782554 PMC: 10841446. DOI: 10.1002/ana.26812.

References
1.
Poser S, Mollenhauer B, Kraubeta A, Zerr I, Steinhoff B, Schroeter A . How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999; 122 ( Pt 12):2345-51. DOI: 10.1093/brain/122.12.2345. View

2.
Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

3.
Geschwind M, Shu H, Haman A, Sejvar J, Miller B . Rapidly progressive dementia. Ann Neurol. 2008; 64(1):97-108. PMC: 2647859. DOI: 10.1002/ana.21430. View

4.
Esposito S, Principi N, Calabresi P, Rigante D . An evolving redefinition of autoimmune encephalitis. Autoimmun Rev. 2018; 18(2):155-163. DOI: 10.1016/j.autrev.2018.08.009. View

5.
Sala I, Marquie M, Sanchez-Saudinos M, Sanchez-Valle R, Alcolea D, Gomez-Anson B . Rapidly progressive dementia: experience in a tertiary care medical center. Alzheimer Dis Assoc Disord. 2011; 26(3):267-71. DOI: 10.1097/WAD.0b013e3182368ed4. View